- Corporate Officers - W
- Watson W. Mark
Insider Trading History of Watson W. Mark
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Watson W. Mark since 2017.
This trader's CIK number is 1612372.
At the time of last reporting, Watson W. Mark was the Director of Vaxart, Inc.. (stock ticker symbol VXRT).
Also see all insider trading activities at Vaxart, Inc..
Note that in the past
Watson W. Mark also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biodelivery Sciences International Inc (BDSI) by Watson W. Mark
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | BDSI | 0 | $0 | 0 | $0 | 7,684 | $0 |
2021 | BDSI | 0 | $0 | 0 | $0 | 30,000 | $0 |
2020 | BDSI | 0 | $0 | 13,000 | $67,340 | 30,000 | $0 |
2019 | BDSI | 0 | $0 | 0 | $0 | 24,739 | $0 |
2018 | BDSI | 0 | $0 | 0 | $0 | 9,740 | $0 |
Yearly summary of insider trading at Sykes Enterprises Inc (SYKE) by Watson W. Mark
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | SYKE | 0 | $0 | 3,000 | $78,300 | 0 | $0 |
Yearly summary of insider trading at Vaxart, Inc. (VXRT) by Watson W. Mark
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | VXRT | 10,000 | $4,050 | 0 | $0 | 0 | $0 |
2024 | VXRT | 20,000 | $13,580 | 0 | $0 | 0 | $0 |
2022 | VXRT | 40,000 | $30,280 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Inhibitor Therapeutics, Inc. (HPPI) by Watson W. Mark
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | HPPI | 0 | $0 | 0 | $0 | 900,000 | $0 |
Insider trading activities at 4 companies by Watson W. Mark:
1. Biodelivery Sciences International Inc (BDSI)
2. Sykes Enterprises Inc (SYKE)
3. Vaxart, Inc. (VXRT)
4. Inhibitor Therapeutics, Inc. (HPPI)
Table 1. Insider trading of Biodelivery Sciences International Inc (BDSI) by Watson W. Mark
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-01-27 | BDSI | Option Ex | 7,684 | .00 | 0 |
2021-08-06 | BDSI | Option Ex | 30,000 | .00 | 0 |
2020-08-17 | BDSI | Sale | 13,000 | 5.18 | 67,340 |
2020-08-07 | BDSI | Option Ex | 30,000 | .00 | 0 |
2019-08-13 | BDSI | Option Ex | 24,739 | .00 | 0 |
2018-08-14 | BDSI | Option Ex | 9,740 | .00 | 0 |
Table 2. Insider trading of Sykes Enterprises Inc (SYKE) by Watson W. Mark
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-03-30 | SYKE | Sale | 3,000 | 26.10 | 78,300 |
Table 3. Insider trading of Vaxart, Inc. (VXRT) by Watson W. Mark
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-07-29 | VXRT | Buy | 10,000 | .41 | 4,050 |
2024-06-18 | VXRT | Buy | 20,000 | .68 | 13,580 |
2022-12-28 | VXRT | Buy | 20,000 | .76 | 15,140 |
2022-12-28 | VXRT | Buy | 20,000 | .76 | 15,140 |
Table 4. Insider trading of Inhibitor Therapeutics, Inc. (HPPI) by Watson W. Mark
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-03-08 | HPPI | Option Ex | 900,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Watson W. Mark
(Director of Vaxart, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.